Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Randomized Double Blind Clinical Trial in Mali, Comparing the Effectiveness of Artesunate + Sulfamethoxypyrazine/Pyrimethamine Versus Praziquantel in the Treatment of S. Haematobium in Children

NCT00510159 is registered in ClinicalTrials.gov with Dafra Pharma as lead sponsor.

NCT NCT00510159
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT00510159 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Randomized Double Blind Clinical Trial in Mali, Comparing the Effectiveness of Artesunate + Sulfamethoxypyrazine/Pyrimethamine Versus Praziquantel in the Treatment of S. Haematobium in Children
Lead sponsor
Dafra Pharma
Phase
Phase 2/3
Overall status
Completed
Start date
August 31, 2007
Completion date
December 31, 2007
Enrollment
800 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

schistosoma haematobium